Compounds and methods for modulating FX-receptors
US7863302B2 · kind B2 · utility
17Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2007 |
| Grant date | Jan 4, 2011 |
| Priority date | — |
| Expiry date | Jan 1, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.